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ABSTRACT
Colonic contractility normally shows circadian variability regulated by sleep and especially food intake. 
However, individuals with type 1 diabetes have a reduced or even absent gastrocolic response to a meal, 
indicating that colonic contractility may be affected by the disease. We hypothesized that individuals with 
type 1 diabetes and distal symmetric polyneuropathy (DSPN) have decreased motility (expressed as the 
motility index) and contractility of the colon and a reduced increase in motility index from night to morning 
compared to healthy controls and individuals with type 1 diabetes without DSPN. Cohorts of 35 individuals 
with type 1 diabetes and DSPN, 40 individuals with type 1 diabetes without DSPN, and 28 healthy controls 
were included in this post-hoc, cross-sectional analysis. We investigated, using a wireless motility capsule that 
measures pH, temperature, and pressure throughout the gastrointestinal tract, whether individuals with type 
1 diabetes with and without DSPN, compared to healthy controls, exhibit altered colonic contractility in the 
evening, night, and morning. Max amplitude, mean peak amplitude, mean contraction, and motility index of 
the colon were calculated at the afore-designated times. Motility index of the colon tended to be higher in 
individuals with type 1 diabetes and DSPN compared to controls in the evening (P = .064), but the effect size 
was small (1.74%). There was no difference in motility index between the groups in the morning or evening. 
Furthermore, there was no difference in max amplitude, mean peak amplitude, or mean contraction between 
groups in the morning, evening, and night. As expected, overall contractility increased from night to morning 
in all groups, but there was no difference between groups in the increase in contractility from night to 
morning. Colonic contractility generally peaked in the morning, decreased in the evening, and was almost 
absent at night. Type 1 diabetes and/or DSPN did not impair contractility of the colon at any time point. 
Contractility and motility increased from morning to night unaffected by type 1 diabetes and/or DSPN.
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Introduction
Type 1 diabetes is associated with numerous complications, 
including polyneuropathy which develops in up to 50% of 
such individuals. Plausibly, prolonged hyperglycemia 
causes disruption of coordinated gastrointestinal function 
(Domènech et al. 2011), leading to pleomorphic and non-
specific symptoms including, e.g., nausea, early satiety, 
abdominal pain, diarrhea, constipation, or fecal inconti-
nence (Meldgaard et al. 2018). Intestinal cells contain an 
intrinsic circadian clock, or ‘gut clock’, which ensures that 
the processing of food occurs in daily cycles (Asher and 
Sassone-Corsi 2015). The central clock in the suprachias-
matic nucleus of the brain is primarily controlled by light/ 
dark cycles, and the peripheral gut clock is primarily con-
trolled by eating patterns, independent of the central clock 
(Zarrinpar et al. 2016). Normal colonic contractility is 
regulated by circadian rhythms and especially by sleep 
and food intake. In diurnally active healthy individuals, 
the number of colonic pressure waves and periods of colo-
nic activity are reduced in the night compared to the day-
time (Rao et al. 2001). Furthermore, pressure activity 
increases rapidly upon wakening and after a meal (Rao 
et al. 2001). In contrast, it has been shown that individuals 
with type 1 diabetes and mild to severe constipation have 
a reduced, delayed or even absent gastrocolic response to 
a meal (Battle et al. 1980), indicating that the regulation and 
coordination of colonic motility may be affected by diabetes 
and that this may contribute to the diversity of gastrointest-
inal symptoms reported by people with type 1 diabetes with 
or without distal symmetric polyneuropathy (DSPN) 
(Gregersen et al. 2016). It is unknown, however, whether 
circadian variation in colonic contractility is altered in 
individuals with type 1 diabetes with or without DSPN.
We hypothesized that individuals with type 1 diabetes 
and DSPN have decreased motility (expressed as the 
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motility index) and contractility of the colon and 
a reduced increase in motility index from night to morn-
ing compared to healthy control individuals and indivi-
duals with type 1 diabetes without DSPN. We thus 
investigated whether colonic motility and contractility is 
affected in individuals with type 1 diabetes and DSPN, in 
comparison to individuals with type 1 diabetes without 
DSPN and healthy controls, in the morning, evening, and 
night. Furthermore, we assessed whether the increase in 
colonic motility and contractility from night to morning, 
previously observed in healthy individuals, is blunted in 
individuals with type 1 diabetes with or without DSPN.
Materials and methods
Study population
Thirty-five individuals with type 1 diabetes and confirmed 
DSPN according to the Toronto criteria including clinical 
signs and nerve testing, (T1D/+DSPN), 40 individuals 
with type 1 diabetes without any clinical signs of DSPN 
(T1D/-DSPN), and 28 healthy control individuals (CON) 
were included in the analyses (Table 1). The participants 
adhered to a routine of diurnal activity and nighttime 
sleep (Table 1). The participants are derived from three 
different studies (described in the online supplementary 
material). All participants gave written informed consent 
before any study procedure was initiated. The studies were 
approved by the ethical committees of the North Region of 
Denmark and the Capital Region of Denmark. Data can be 
provided upon request to the corresponding author.
Study protocol
In the morning, following an overnight fast of at least 6 h, 
participants ingested a SmartBar® (Medtronic, 
Minneapolis, USA, 260 kcal, 3% fat, 21% protein, 75% 
carbohydrate, 3% fiber) with 200 mL of water followed by 
a wireless motility capsule (WMC) (Smartpill®, Medtronic, 
Minneapolis, USA). The WMC technique has previously 
been described in detail (Farmer et al. 2018; Maqbool et al. 
2009; Rouphael et al. 2017). Briefly, the WMC is an ambu-
latory, noninvasive, radiation-free, indigestible capsule that 
measures temperature, pH, and pressure as it passes 
through the gastrointestinal tract. Data are continuously 
transmitted to an external data receiver worn by the 
participant.
The time of ingestion was scheduled in the morning 
between 08:00 and 10:30 h. Participants were instructed 
to abstain from eating or drinking for 6 h after ingestion 
of the WMC, after which they could resume their daily 
diet and activities.
Participants were instructed to register specific events 
(food ingestion, bowel movement, bedtime, and wake-up 
time) by pressing a button on the data receiver and report-
ing the event in a personal diary. Furthermore, participants 
were instructed to keep the data receiver close to their body 
until expulsion of the capsule, indicated by loss of signal 
after a bowel movement, which was verified by a dramatic 
decrease in temperature on the WMC trace.
Study procedures
Body weight was measured to the nearest 0.1 kg using an 
electronic scale with the participant wearing only light 
clothes. Height was measured to the nearest centimeter 
using a stadiometer. Blood pressure and heart rate were 
measured on the left arm following 5 min of rest, and 
clinical biochemical data were analyzed at the local 
department of clinical biochemistry.
Data analysis
Data were downloaded and analyzed using the MotiliGI 
software (MotiliGI version 3.0, Medtronic, Minneapolis, 
Table 1. Participant characteristics of the control group (CON), type 1 diabetes without DSPN (T1D/-DSPN), and type 1 diabetes with 
DSPN(T1D/+DSPN). Data are presented as median [Q1, Q3] unless otherwise stated. BMI, body mass index; BPM, beats/min; HbA1c, 
Hemoglobin A1c; DSPN, distal symmetric polyneuropathy; T1D, type 1 diabetes; CON, control group.
CON T1D/-DSPN T1D/+DSPN P-value
n 28 40 35
Age (y) 52 [45, 57] 38 [28, 51] 50 [44, 56] 0.005
Women, number (%) 15 (54) 19 (48) 23 (66) 0.022
Height (cm) 175 [169, 182] 174 [167, 177] 180 [174, 184] 0.001
Weight (kg) 70.0 [64.0, 82.3] 74.3 [66.2, 85.1] 85.3 [77.6, 97.4] <0.001
BMI (kg/m2) 23.7 [22.0, 24.6] 25.5 [23.4, 27.3] 27.5 [25.2, 30.0] <0.001
Smokers, number (%) 3 (11) 11 (28) 5 (14) 0.358
Systolic blood pressure (mmHg) 124 [112, 130] 130 [120, 142] 140 [124, 154] 0.001
Diastolic blood pressure (mmHg) 73 [70, 84] 74 [67, 80] 77 [73, 83] 0.032
Resting heart rate (BPM) 66 [59, 74] 69 [63, 76] 73 [70, 79] 0.043
HbA1c (%) 5.3 [5.2, 5.4] 7.5 [7.0, 8.5] 8.1 [7.6, 8.7] <0.001
HbA1c (mmol/mol) 34 [33, 36] 58 [53, 69] 65 [60, 72] <0.001
Disease duration (years) 0 [0, 0] 20 [11, 28] 31 [25, 40] <0.001
Wake up time (h:min) 06:45 [06:15, 07:00] 07:00 [06:00, 08:00] 06:30 [06:00, 07:15] 0.529
Bedtime (h:min) 22:30 [22:00, 23:00] 22:30 [22:00, 23:15] 23:00 [22:30, 23:30] 0.044
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USA). A 1 h time frame was analyzed at each of three time 
points: evening (1 h before bedtime), at night (1 h from 
the lowest detectable temperature between bedtime and 
wake-up time), and morning (1 h from wake-up time). 
Time frames containing >10% signal loss were excluded 
from the analysis. Observations were excluded from the 
analysis (Figure S1, online supplementary material) when 
the bedtime and/or wake-up time were not reported by 
the participant.
For each of the three time points, four contractility 
measures were calculated using the MotiliGI software: 1) 
max amplitude (maximum amplitude within the selected 
time frame), 2) mean peak amplitude (mean amplitude/ 
contraction), 3) mean contraction (mean number of con-
tractions/min), and 4) motility index. The motility index 
was calculated by the software as the natural log of the 
sum of amplitudes*number of contractions + 1 (Farmer 
et al. 2013) and expressed in mmHg*S/min. Furthermore, 
the difference from night to morning of the four contrac-
tility measures was calculated as a morning/night ratio.
Statistical analyses
A one-way ANOVA adjusted for sex and age was used to 
test the effect of group on each of the outcomes at each time 
point (evening, night, morning). Sex and age have pre-
viously been observed to impact gastrointestinal motility 
(Wang et al. 2015), and since these confounders were not 
equally distributed among the groups, the analyses were 
adjusted for these two factors. Data with non-normally 
distributed residuals or unequal variance were log- 
transformed before analysis. In case of significant group 
effects, a Tukey HSD post-hoc test was applied to test 
between-group differences. For participant characteristics, 
a Kruskal–Wallis test was used to test the effect of group. 
Data are presented as medians [Q1;Q3]. Differences 
between groups are presented as mean (95% confidence 
interval). Statistical analyses were performed using RStudio 
version 1.1.463 (RStudio, Boston, MA, USA).
Results
Participant characteristics
Participant characteristics are presented in Table 1. 
Individuals with T1D/-DSPN were younger (P = .005) 
and had a shorter disease duration (P = <0.001) compared 
to T1D/+DSPN. The proportion of women (P = .022) as 
well as mean BMI (P = <0.001) and HbA1c (P = <0.001) 
were higher in the T1D/+DSPN group compared to the 
other groups.
Effect on colonic contractility in type 1 diabetes with 
or without DSPN
There was a group-dependent effect on motility index in 
the evening (P = .042; Figure 1d). The post-hoc test 
showed that the motility index tended to be higher in 
T1D/+DSPN compared to CON in the evening, with 
a mean difference of 1.74% (95% CI: 1.08; 2.81%, 
P = .064) (Figure 1d). There was no difference in motility 
index between groups in the morning or night. 
Furthermore, there was no difference between groups in 
max amplitude, mean peak amplitude, or mean contrac-
tion at any of the three time points (Figure 1a–c). Finally, 
there was no difference between groups in the delta of the 
morning vs. night values of any of the contractility mea-
sures (Figure 2a–d).
Temporal variation in colonic contractility
In general, max amplitude, mean contraction, and moti-
lity index peaked in the morning, decreased in the eve-
ning, and was lowest at night (Figure 1a,c,d), whereas 
mean peak amplitude was comparable between the three 
time points (Figure 1b).
Discussion
Colonic contractility was measured by the WMC techni-
que in three cohorts, and we found that the presence of 
type 1 diabetes and DSPN, with reference to CON, did not 
seem to change colonic contractility in the morning, eve-
ning, or at night. A tendency toward a slightly higher 
motility index in individuals with T1D/+DSPN compared 
to CON in the evening was observed; however, this is 
presumably clinically irrelevant due to the small effect 
size. This notion is supported by the fact that our T1D/ 
+DSPN cohort had markedly prolonged colonic transit 
compared to healthy controls (Farmer et al. 2017), which – 
at least in healthy individuals – seems contradictory to an 
increased motility index. Consequently, the combination 
of decelerated colonic transit and equal or even increased 
motility index in individuals with T1D/+DSPN suggests 
that the neuronal support of colonic contractility and 
propulsion may be disrupted, uncoordinated, and less 
effective in the presence of type 1 diabetes and DSPN.
We did confirm that colonic motility exhibits tem-
poral variation, with the difference between the night 
and morning values being the most pronounced. This is 
in accordance with previous studies, showing that pres-
sure activity increased rapidly (threefold) upon waken-
ing (Rao et al. 2001). The increase in contractility and 
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motility from night to morning previously observed in 
healthy individuals was, however, also seen in indivi-
duals with T1D/+DSPN. Therefore, our hypothesis that 
individuals with T1D/+DSPN have a reduced increase in 
motility index of the colon from night to morning com-
pared to CON and T1D/-DSPN was not confirmed. This 
implies that even though the gut is in fact affected by 
diabetes as shown previously (Farmer et al. 2017), the 
intrinsic circadian gut clock may not be affected. In 
contrast, mice with streptozotocin-induced type 1 dia-
betes expressed a decrease in amplitude and a phase 
delay in their mRNA expression of clock genes per2 
and per3 in the colon (Bostwick et al. 2010). In addition, 
it has previously been demonstrated that per1per2 dou-
ble knockout mice lack the natural circadian rhythmicity 
in intracolonic pressure changes and colonic circular 
muscle contractility compared to wildtype mice 
(Hoogerwerf et al. 2010), suggesting that normal rhyth-
micity of these clock genes is necessary to maintain 
circadian rhythmicity. However, it is unknown whether 
these findings also apply to humans.
Individuals with type 1 diabetes experience a wide 
range of gastrointestinal symptoms, ranging from severe 
constipation to chronic diarrhea or fecal incontinence 
(Meldgaard et al. 2018) that are characterized by differ-
ent colonic motility patterns. An absent gastrocolic 
response to a meal has been observed in individuals 
with type 1 diabetes with severe constipation, whereas 
individuals with type 1 diabetes with mild constipation 
and healthy controls had increased colonic contractility 
in response to a meal (Battle et al. 1980). Thus, symptom 
severity may reflect the degree of neuronal damage. 
Furthermore, slow transit constipation causes impaired 
contractility measured with the WMC in the morning 
compared to normal transit constipation and healthy 
bowel habits (Surjanhata et al. 2016). In the present 
study, we did not characterize gastrointestinal symp-
toms of the participants, and, therefore, we cannot rule 
out that a large variation in participant phenotypes may 
explain our findings.
There are several limitations to this study. Firstly, 
data for the present study represent secondary analyses; 
Figure 1. Box and whisker plots demonstrating max amplitude (a), mean peak amplitude (b), mean contraction (c), and motility index 
(d) in the control group (CON) (evening: n = 25, night: n = 28, morning: n = 23), type 1 diabetes without DSPN (T1D/-DSPN) (evening: 
n = 36, night: n = 36, morning: n = 26), and type 1 diabetes with DSPN (T1D/+DSPN) (evening: n = 30, night: n = 32, morning: n = 30). 
Purple boxes = CON, teal boxes = T1D/+DSPN, yellow boxes = T1D/-DSPN. Effect of group adjusted for sex and age was assessed by 
one-way ANOVA at each time-point, and a Tukey post-hoc test was applied to asses between-group differences. Overall effect of group 
is marked by a line with p-value. DSPN, distal symmetric polyneuropathy; T1D, type 1 diabetes; CON, control group.
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however, the WMC procedures were similar between 
the studies, and only 13 of the 103 participants ingested 
the WMC approximately 0.5–1.5 h later in the morning 
than specified. The WMC measures pressure, but it 
cannot distinguish between propagating or retrograde 
peristalsis, or if the pressure is simply a result of unco-
ordinated static muscle tone. Therefore, we were not 
able to distinguish the effectiveness and propulsion of 
colonic peristalsis between the groups. Furthermore, 
others have shown that pressure activity of the trans-
verse/descending colon is significantly higher than in the 
rectosigmoid colon within the first hour after meal 
ingestion (Rao et al. 2000). Since it is not possible to 
distinguish the different segments of the colon using the 
WMC, the segmental difference in colonic pressure 
activity may have impacted the results of our study.
We did not control the food intake of the participants 
prior to or during the study, which may have influenced 
our results. Especially the dietary fiber content of food prior 
to the test day affects colonic motility dramatically, e.g., 
eating an additional 9 g of dietary fiber for 3d has been 
shown to decrease colonic transit time by 10.8 h (Timm 
et al. 2011). Also, food consumption in proximity to the 
time frames of interest would elicit a gastrocolic response 
and affect the measurement (Battle et al. 1980). However, 
standardizing the timing and composition of food intake 
could disturb the natural circadian rhythm of the partici-
pants’ gastrointestinal tract, and, therefore, we aimed at 
maintaining the natural rhythm of the individuals.
In summary, the presence of T1D/+DSPN did not 
seem to affect contractility of the colon in the morning, 
evening, or night in the present study. We did, however, 
confirm that colonic contractility is in general greatest in 
the morning and almost absent at night.
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